1 / 12

Variation Among Immunoreactive Trypsinogen Concentrations, Michigan Newborn Screening, 10/2007-4/2008

Variation Among Immunoreactive Trypsinogen Concentrations, Michigan Newborn Screening, 10/2007-4/2008. Steven J. Korzeniewski, MA, MSc, Maternal & Child Health Epidemiology Section Manager Grigorescu, V., Young, W., Hawkins, H., Cavanaugh, K., Nasr, S.Z., Langbo, C. Outline . Background

issac
Download Presentation

Variation Among Immunoreactive Trypsinogen Concentrations, Michigan Newborn Screening, 10/2007-4/2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Variation Among Immunoreactive Trypsinogen Concentrations, Michigan Newborn Screening, 10/2007-4/2008 Steven J. Korzeniewski, MA, MSc, Maternal & Child Health Epidemiology Section Manager Grigorescu, V., Young, W., Hawkins, H., Cavanaugh, K., Nasr, S.Z., Langbo, C.

  2. Outline Background Research question Methods Results Discussion Public Health Implications

  3. Background CF Screening in MI commenced Oct. 2007 IRT is used to identify infants at increased risk of CF for DNA testing. Mutation analysis, using a panel of 40 CF mutations among > 96th percentile. In the absence of a mutation sweat testing is recommended only among infants having IRT concentrations > 99.8th percentile.

  4. Research Question Anecdotal evidence suggested a high rate of false positives among NICU infants This study explores variations in IRT concentrations in hopes of developing a strategy to reduce false positives. R1: Do IRT concentrations vary among the general population by sex, race, birth weight, gestational age, and fetal growth ratio?

  5. Methods Data: Newborn screening IRT concentrations and infant demographic data collected from Oct 2007-April 2008 were used for this study. Analysis: Crude and adjusted generalized linear models (GLM) of the association between demographic variables and IRT concentrations Least squares means and p-values are reported LS-means are within-group adjusted means, they estimate the marginal means for a balanced population (as opposed to the unbalanced design). Also called estimated population marginal means by Searle, Speed, and Milliken (1980). We also calculated means and percentiles (96th, 99.8th) by race and gestational age strata

  6. Results

  7. Results

  8. Updated Results At one year (Oct 2007-Oct 2008) Effect modification of race by gestational age absolved Racial variation remained significant in both crude & adjusted models

  9. Conclusion Failure to account for racial variation results in: Over sampling of black infants those at lower risk of CF Under sampling of white infants those at the greater risk of CF False positive and false negative rates could be inflated However, no false negatives have been detected thus far

  10. Public Health Implications Calculation of IRT % cutoffs stratified by race would: Reduce the FPR & Improve PPV Require further research to discern appropriate cutoffs, particularly for racial minorities or those with missing data Require significant change in laboratory operating procedures Sorting of cards Verification of Race information Development of strategy to calculate cutoffs over time

  11. Acknowledgements Co-Investigators: Grigorescu, V., Young, W., Hawkins, H., Cavanaugh, K., Nasr, S.Z., Langbo, C. NBS Follow-up Staff CF Advisory Committee

  12. Contact KorzeniewskiS@Michigan.gov Thank You

More Related